IGF2BP1 is mainly localized in renal TECs [48]; thus, the IGF2BP1-mediated E2F1/MIF pathway in renal TECs may be a valuable target to mitigate septic acute kidney injury. This evidence concerns the gene MIF and acute kidney injury.